Encysive Pharmaceuticals (ENCY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Encysive Pharmaceuticals (ENCY)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: idos	12/14/2006 9:23:18 AM
	Read Replies (1) of 205

Unbelievable - the never ending story of Thelin: Encysive says FDA finds response to Thelin incomplete Dec 14 (Reuters) - Encysive Pharmaceuticals Inc. (ENCY.O: Quote, Profile , Research) said the U.S. Food and Drug Administration has found its response to a July "approvable letter", for its experimental treatment Thelin incomplete. The Houston, Texas-based company said it expects to provide the requested information related to the treatment, which is for an often-fatal lung condition, within several days, and is hopeful this will resolve any remaining questions. (Reporting by Sweta Singh in Bangalore.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next